SARCOMA CONNECT has summarised highlights of the recent ESMO 2019 meeting for you

Sebastian Bauer (MD) underwent his medical training at the University of Würzburg, Germany and his resisdency and medical oncology fellowship at the University of Duisburg-Essen, Germany. He is committed to clinical care, clinical research and translational, lab-based research in sarcomas. He is Professor of Translational Oncology (Personalized Cancer Therapy) at the Dept. of Medical Oncology,  University Hospital Essen as well as Director of the Sarcoma Center at the West German Tumor Center, one of the largest sarcoma programs in Europe. Dr Bauer has served as principal investigator in more than 50 clinical trials in bone, soft-tissue sarcomas, including gastrointestinal stromal tumors. His research group is focused on model development,  resistance mechanisms to targeted treatments (primarily in GIST) and academic drug development. He is member of the steering committee of the German Sarcoma Study Group (AIO), member of the EORTC (STBSG) and board member of the German Sarcoma Foundation. He has in the past served as ESMO sarcoma track chair and is currently member of the sarcoma sub-committee. He is a regular reviewer for cancer-related journals and sarcoma meetings (CTOS, ESMO).

Programme summary
  • clock Duration 5 MIN
  • clock Language(s) flag
Watch the video now
Share this programme
This educational programme is supported by an Independent Medical Education Grant from Bayer
I agree that this educational programme:

Was valuable to me

1/4
Brought to you by
SARCOMA CONNECT

SARCOMA CONNECT is an initiative of COR2ED, supported by Independent Medical Educational Grants from Bayer and Karyopharm Therapeutics.

Meet the experts

Other programmes of interest

Conference update
Oncology 
Oncogene-addicted NSCLC: Highlights from ASCO 2024

The latest non-small cell lung cancer data presented at ASCO

Experts
Prof. Nicolas Girard
  • download Downloadable
    Resources
  • clock 3 MIN
  • calendar Jun 2024

Educational programme supported by an Independent Medical Education grant from Bayer.
Upper lower GI cancer update ASCO 2024 Conference update
Oncology 
Upper and lower GI cancer update from ASCO 2024

GI oncologists review the latest data presented at ASCO 2024

Experts
Dr Samuel J Klempner, Dr Elizabeth Smyth, Prof. Jenny Seligmann, Dr Dominik Modest
  • clock 8 MIN
  • calendar Jun 2024

Educational programme supported by an Independent Medical Education grant from Bayer.
Experts Knowledge Share Video
Oncology Hemato-oncology 
Optimising the management of multiple myeloma in the early relapsed/refractory setting (RRMM)

Medical experts discuss the latest learnings from clinical practice

Experts
Prof. Aurore Perrot, Prof. Hermann Einsele, Assoc. Prof. Karthik Ramasamy, Assoc. Prof. Joshua Richter
  • download Downloadable
    Resources
  • clock 76 MIN
  • calendar Jun 2024

Educational programme supported by an Independent Medical Education grant from Menarini Stemline Oncology.
Conference update

Episode

1

of 4

episode
Oncology 
ASCO 2024 lung cancer highlights

A conference update on lung cancer clinical trial data from ASCO

Experts
Prof. Mark Socinski
  • clock 4 MIN
  • calendar Jun 2024

Conference update

Episode

2

of 4

episode
Oncology 
ASCO 2024 breast cancer highlights

How could the data impact clinical practice?

Experts
Prof. Shaheenah Dawood
  • clock 3 MIN
  • calendar Jun 2024

Conference update

Episode

3

of 4

episode
Oncology 
ASCO 2024 HCC highlights

How could the latest clinical trial data impact the management of hepatocellular carcinoma?

Experts
Prof. Dr Peter R. Galle
  • clock 1 MIN
  • calendar Jun 2024